Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 207,850 $ 187,353
Short-term restricted cash 964 982
Short-term investments 18,681 18,529
Accounts receivable, net 188,733 170,971
Inventory 149,585 160,544
Prepaid expenses and other current assets 27,773 24,745
Total current assets 593,586 563,124
Long-term restricted cash 22 22
Property and equipment, net 77,691 79,018
Leased right-of-use assets 26,357 28,515
Intangible assets, net 96,352 109,316
Goodwill 318,910 306,739
Deferred tax assets 57,515 66,491
Other long-term assets 28,045 26,800
Total assets 1,198,478 1,180,025
Current liabilities:    
Accounts payable 54,578 68,576
Accrued price protection liability 103,797 113,274
Accrued expenses and other current liabilities 112,943 100,155
Accrued compensation 28,844 59,081
Total current liabilities 300,162 341,086
Long-term lease liabilities 21,239 23,353
Long-term debt 121,910 121,757
Other long-term liabilities 21,055 17,444
Total liabilities 464,366 503,640
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 79,981 shares issued and outstanding at March 31, 2023 and 78,745 shares issued and outstanding December 31, 2022 8 8
Additional paid-in capital 771,164 722,778
Accumulated other comprehensive loss (1,213) (1,021)
Accumulated deficit (35,847) (45,380)
Total stockholders’ equity 734,112 676,385
Total liabilities and stockholders’ equity $ 1,198,478 $ 1,180,025